Changes in RSV-associated lower respiratory tract infections among hospitalized and outpatient children under 2 years in Northern Bavaria after general recommendation of Nirsevimab immunization in 2024
We observed a clear decrease of RSV-LRTI in hospitalized and outpatient infants < 1 year of age in the first RSV season, suggesting a relevant impact following Nirsevimab recommendation in Germany.
Authors
- Johannes G. Liese (ORCID: https://orcid.org/0000-0002-5569-4914)
- Géraldine Engels (ORCID: https://orcid.org/0000-0003-0873-3631)
- Andrea Streng (ORCID: https://orcid.org/0000-0003-2377-7106)
- Katharina Hecker
- Oliver Andrés (ORCID: https://orcid.org/0000-0002-1510-4051)
- Benedikt Weißbrich
- Kerstin Knies
- Christoph Härtel (ORCID: https://orcid.org/0000-0002-2181-7322)
- Christine D. Krempl
- Ying Zhou (ORCID: https://orcid.org/0000-0002-4419-8309)
Institutions
- University of Würzburg (DE)
- Universitäts-Kinderklinik Würzburg (DE)
- Universitätsklinikum Würzburg (DE)
Publication Details
- Journal
- Infection
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1007/s15010-025-02654-1
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Sanofi